279 related articles for article (PubMed ID: 10984888)
1. Age- and sex-related bone uptake of Tc-99m-HDP measured by whole-body bone scanning.
Brenner W; Sieweke N; Bohuslavizki KH; Kampen WU; Zuhayra M; Clausen M; Henze E
Nuklearmedizin; 2000 Aug; 39(5):127-32. PubMed ID: 10984888
[TBL] [Abstract][Full Text] [Related]
2. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
[TBL] [Abstract][Full Text] [Related]
3. Quantification of diphosphonate uptake based on conventional bone scanning.
Brenner W; Bohuslavizki KH; Sieweke N; Tinnemeyer S; Clausen M; Henze E
Eur J Nucl Med; 1997 Oct; 24(10):1284-90. PubMed ID: 9323270
[TBL] [Abstract][Full Text] [Related]
4. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
5. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
Brenner W; Kampen WU; Kampen AM; Henze E
J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
[TBL] [Abstract][Full Text] [Related]
6. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
7. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
Ergün EL; Kiratli PO; Günay EC; Erbaş B
Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
[TBL] [Abstract][Full Text] [Related]
8. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
[TBL] [Abstract][Full Text] [Related]
9. (89)Sr bremsstrahlung single photon emission computed tomography using a gamma camera for bone metastases.
Ota S; Uno M; Kato M; Ishiguro M; Natsume T; Kikukawa K; Tadokoro M; Ichihara T; Toyama H
Ann Nucl Med; 2014 Feb; 28(2):112-9. PubMed ID: 24297387
[TBL] [Abstract][Full Text] [Related]
10. Diffuse lung and stomach uptake of Tc-99m oxidronate (HDP).
Esser JP; Oei HY; Kwekkeboom DJ; Krenning EP
Clin Nucl Med; 2003 Oct; 28(10):845-6. PubMed ID: 14508280
[No Abstract] [Full Text] [Related]
11. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
[TBL] [Abstract][Full Text] [Related]
12. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
13. Global skeletal uptake of 99mTc-methylene diphosphonate (GSU) in patients affected by endocrine diseases: comparison with biochemical markers of bone turnover.
Scillitani A; Dicembrino F; Chiodini I; Minisola S; Fusilli S; Di Giorgio A; Garrubba M; D'Aloiso L; Frusciante V; Torlontano M; Modoni S; Trischitta V; Trischitta V; Carnevale V
Osteoporos Int; 2002 Oct; 13(10):829-34. PubMed ID: 12378373
[TBL] [Abstract][Full Text] [Related]
14. [Clinical usefulness of 201Tl-chloride scintigraphy for the evaluation of metastatic bone lesions].
Fukui A; Kawamura M; Kataoka M; Fujii T; Yamamoto K; Yoshioka S; Ikezoe J
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jan; 58(1):25-33. PubMed ID: 9493430
[TBL] [Abstract][Full Text] [Related]
15. Age-related change of technetium-99m-HMDP distribution in the skeleton.
Kigami Y; Yamamoto I; Ohnishi H; Miura H; Ohnaka Y; Ota T; Yuu I; Masuda K; Morita R
J Nucl Med; 1996 May; 37(5):815-8. PubMed ID: 8965151
[TBL] [Abstract][Full Text] [Related]
16. Three-phase bone scintigraphy in chronic epicondylitis.
Pienimäki TT; Takalo RJ; Ahonen AK; Karppinen JI
Arch Phys Med Rehabil; 2008 Nov; 89(11):2180-4. PubMed ID: 18996248
[TBL] [Abstract][Full Text] [Related]
17. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89.
Manetou A; Limourls GS
Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243
[TBL] [Abstract][Full Text] [Related]
18. [Diffusely increased uptake in the skull in normal bone scans].
Suematsu T; Yoshida S; Motohara T; Fujiwara H; Nishii H; Komiyama T; Yanase M; Mizutani M
Kaku Igaku; 1992 May; 29(5):599-605. PubMed ID: 1434074
[TBL] [Abstract][Full Text] [Related]
19. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
20. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]